Two Routes to the Same Answer
The Clinical Insurance Funnel
Best if you have a physician managing your care, meet insurance coverage criteria, and want the test billed through your plan. The path runs through appointments, eligibility checks, pre-authorization, and claims — thorough, but slow and price-opaque until the explanation of benefits arrives.
The At-Home, No-Referral Model
Best if you want to know your status now — without waiting for a referral or gambling on a claim. Published $499 price (or $89/mo membership with all 11 tests), cheek swab at home with an FDA-cleared collection device, results in 5–7 days (48-hour priority processing available), counselor included. We also pre-verify insurance if you’d rather bill your plan.
Side-By-Side Comparison
[ Facts As Of August 2026 ]| Feature | Gene Matrix (GeneCancer) | Myriad MyRisk |
|---|---|---|
| Access ModelThe defining difference: who can order the test, and how fast. | Direct-to-consumer — order online, no referral. Insurance pre-verification available if you prefer to bill your plan. | Physician-ordered only (as of 2026). Requires a provider visit, eligibility review, and insurance pre-authorization. |
| Panel SizeBoth are multi-gene hereditary cancer panels; breadth differs. | 108 genes — BRCA1/2, Lynch syndrome, PALB2, TP53, CDH1, STK11, PTEN, and 100+ more, across 15+ cancer types. | Multi-gene hereditary cancer panel (historically ~30–50 genes depending on panel version) with Myriad’s riskScore for eligible patients. |
| Price TransparencyPublished prices let you decide before you commit. | $499 one-time, or included with the $89/mo membership ($59/mo billed annually, $712/yr) with all 10 other tests. HSA/FSA accepted. | Insurance-billed; list prices not publicly posted, historically in the thousands. Patient cost depends on coverage and Myriad’s assistance programs. |
| Sample CollectionConvenience without compromising lab quality. | Cheek swab at home — FDA-cleared collection device, prepaid return mailer, free shipping both ways. | Blood draw or saliva sample collected through the ordering clinic. |
| TurnaroundClock starts at lab receipt — but the DTC path skips the appointment queue. | 5–7 days from lab receipt; 48-hour priority processing for members. | Typically 2–4 weeks through the clinical funnel, after scheduling and authorization. |
| Lab GradeBoth meet the federal clinical standard. | CLIA-certified, CAP-accredited (CLIA ID 14D2276402). NGS at up to 99.9% analytical accuracy, validated against Sanger sequencing. | CLIA-certified laboratory; decades of published hereditary cancer experience. |
| Genetic CounselingA positive result needs a plan, not just a PDF. | Board-certified counselor session included with every positive result, with an NCCN-aligned screening plan. | Results managed through the ordering physician; counseling access varies by practice. |
| Beyond CancerOne sample, many answers. | 10 more panels in the same membership — pharmacogenomics, mental health, nutrition, preventive health, and more. | Focused on hereditary cancer and related clinical diagnostics. |
MyRisk® is a registered trademark of Myriad Genetics, Inc. This independent comparison is provided under nominative fair use — no affiliation or endorsement implied. Competitor details verified August 2026; confirm current offerings at myriad.com.
Our Honest Verdict
[ When Each Wins ]
If you’re already inside the clinical system — a physician who knows your history, insurance that covers NCCN-criteria testing — MyRisk through your provider is a sound route with a long clinical track record. But if you want hereditary cancer answers without the referral queue and the billing mystery, Gene Matrix GeneCancer delivers a 108-gene clinical panel at a published $499, swab at home, results in 5–7 days (48-hour priority available) — and membership adds 10 more tests for less than many single clinical panels bill.
Gene Matrix vs MyRisk — FAQs
MyRisk is Myriad Genetics’ hereditary cancer panel, ordered through a physician and billed to insurance — a clinical funnel with appointments, eligibility criteria, and claims. Gene Matrix GeneCancer is a 108-gene hereditary cancer panel you order yourself online: no referral, published pricing ($499 one-time or included with the $89/month membership), at-home cheek swab, results in 5–7 days (48-hour priority processing available). Both use CLIA-certified clinical laboratories.
No — as of 2026, MyRisk is a physician-ordered clinical test. You need a provider to evaluate eligibility, place the order, and receive results. If you want hereditary cancer testing without a referral, Gene Matrix GeneCancer is direct-to-consumer: order online, swab at home, and share the physician-ready report with any doctor.
MyRisk is billed to insurance; list prices are not publicly posted and historically run into the thousands of dollars, with patient out-of-pocket depending on plan coverage and Myriad’s assistance programs. Gene Matrix GeneCancer is a published $499 one-time — or included with the $89/month membership along with all 10 other tests — and we pre-verify your insurance benefits before you order so you know your cost either way.
It depends entirely on the lab. Gene Matrix is a CLIA-certified, CAP-accredited clinical laboratory (CLIA ID 14D2276402) running a 108-gene NGS panel at up to 99.9% analytical accuracy — the same federal quality standard as hospital-ordered testing, with board-certified genetic counseling included with every positive result. The access model is consumer-friendly; the lab work is clinical-grade.